Jade Biosciences, Inc. · NASDAQ:JBIO
Deep Track Capital, LP reported a 8.64% stake in Jade Biosciences, Inc. (Schedule 13G)
Event Apr 28, 2025 · Filed Jun 20, 2025
Deep Track Capital, LP reported a 8.64% stake in Jade Biosciences, Inc., 2,784,648 shares, as a passive investor on Apr 28, 2025. Filed Jun 20, 2025 (Schedule 13G).
- Stake
- 8.64%
- Shares
- 2,784,648
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 8.64% | 2,784,648 |
| Deep Track Biotechnology Master Fund, Ltd. | 8.64% | 2,784,648 |
| David Kroin | 8.64% | 2,784,648 |
Source
Related
- Jade Biosciences, Inc.
- Deep Track Capital, LP
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026
- Schedule 13G/A · Deep Track Capital, LP · Nov 14, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026